Statements (20)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:activeIngredient |
gptkb:trazodone
|
| gptkbp:approvalYear |
2010
|
| gptkbp:approvedBy |
gptkb:FDA
|
| gptkbp:ATCCode |
N06AX05
|
| gptkbp:chemicalClass |
serotonin antagonist and reuptake inhibitor
|
| gptkbp:form |
extended-release tablet
|
| https://www.w3.org/2000/01/rdf-schema#label |
Oleptro
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:manufacturer |
Angelini Labopharm
|
| gptkbp:market |
discontinued
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
nausea
dizziness headache drowsiness dry mouth |
| gptkbp:usedFor |
gptkb:major_depressive_disorder
|
| gptkbp:bfsParent |
gptkb:Trazodone
|
| gptkbp:bfsLayer |
7
|